ArticleFrontiers in oncology2025
Case Report: Rare case of signet ring gastric adenocarcinoma with rectal metastasis.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric cancer remains a leading cause of cancer-related mortality worldwide, with the liver, peritoneum, lungs, and bones being the most common sites of metastasis. Rectal metastasis, also referred to as Schnitzler's metastasis, is extremely rare and may clinically mimic primary rectal carcinoma, complicating diagnosis and delaying appropriate management. We report a case of a 69-year-old male diagnosed with signet-ring cell gastric adenocarcinoma who presented with symptoms of large bowel obstruction and constitutional decline. Cross-sectional imaging revealed a circumferential rectal mass and gastric wall thickening. Endoscopic biopsies of both gastric and rectal lesions confirmed poorly cohesive adenocarcinoma with signet ring features. Immunohistochemistry supported gastric origin of the rectal tumor. The patient underwent laparoscopic-assisted transverse colostomy for symptomatic relief but the planned gastrojejunostomy was abandoned due to extensive peritoneal involvement. He was treated with palliative chemotherapy (FOLFOX followed by modified de Gramont), achieving only transient radiologic response before clinical deterioration. Subsequent progression to lymphangitic carcinomatosis led to a shift toward best supportive care. This case highlights the diagnostic challenge posed by rectal metastasis from gastric cancer and underscores the aggressive nature and poor chemotherapy responsiveness of signet ring cell carcinoma. Clinicians should maintain high suspicion for secondary rectal lesions in patients with diffuse-type gastric cancer and lower gastrointestinal symptoms. Timely endoscopy, comprehensive histopathologic evaluation, and tailored palliative strategies remain essential to optimizing outcomes in such rare and complex presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.